Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Comparison of 1‐week vs. 2‐ or 4‐week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication

View through CrossRef
Background: Helicobacter pylori eradication therapies based on ranitidine bismuth citrate have recently been introduced in clinical practice.Aim:To compare the efficacy of three regimens containing ranitidine bismuth citrate given for 1, 2 and 4 weeks, combined with two antibiotics for the first week, in the eradication of H. pylori.Methods:Eighty‐six consecutive patients (50 duodenal ulcer disease, 36 non‐ulcer dyspepsia) with H. pylori infection were offered three eradication regimens: (a) 1‐week group (n=28), ranitidine bismuth citrate 400 mg b.d. for 7 days; (b) 2‐week group (n=29), ranitidine bismuth citrate 400 mg b.d. for 14 days; and (c) 4‐week group (n=29), ranitidine bismuth citrate 400 mg b.d. for 28 days. In all patients, clarithromycin 500 mg b.d. and metronidazole 500 mg b.d. were given for the first week. Endoscopy was repeated 1 month after the end of treatment and eradication was considered to be successful if both rapid urease test and histology were negative.Results:Overall, H. pylori was eradicated in 84% (72/86) patients on intention‐to‐treat analysis, whereas the per protocol cure rate was 89% (72/81). Eradication rates were 23/27 (85%) (95% confidence interval (CI): 66–96%), 25/27 (92%) (95% CI: 76–99%) and 24/27 (89%) (95% CI: 71–98%) in the 1‐, 2‐ and 4‐week groups, respectively, on per protocol analysis, and 25/28 (82%) (95% CI: 63–94%), 25/29 (86%) (95% CI: 68–96%) and 24/29 (83%) (95% CI: 64–94%), respectively, on intention‐to‐treat analysis (P > 0.05, N.S.). No significant differences were observed between groups concerning duodenal ulcer healing, resolution of symptoms and adverse effects.Conclusions:The 1‐week regimen with ranitidine bismuth citrate, clarithromycin and metronidazole is effective in H. pylori eradication. Prolongation of treatment with ranitidine bismuth citrate for 2 or 4 weeks does not achieve a statistically significant more favourable outcome.
Title: Comparison of 1‐week vs. 2‐ or 4‐week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication
Description:
Background: Helicobacter pylori eradication therapies based on ranitidine bismuth citrate have recently been introduced in clinical practice.
Aim:To compare the efficacy of three regimens containing ranitidine bismuth citrate given for 1, 2 and 4 weeks, combined with two antibiotics for the first week, in the eradication of H.
pylori.
Methods:Eighty‐six consecutive patients (50 duodenal ulcer disease, 36 non‐ulcer dyspepsia) with H.
pylori infection were offered three eradication regimens: (a) 1‐week group (n=28), ranitidine bismuth citrate 400 mg b.
d.
for 7 days; (b) 2‐week group (n=29), ranitidine bismuth citrate 400 mg b.
d.
for 14 days; and (c) 4‐week group (n=29), ranitidine bismuth citrate 400 mg b.
d.
for 28 days.
In all patients, clarithromycin 500 mg b.
d.
and metronidazole 500 mg b.
d.
were given for the first week.
Endoscopy was repeated 1 month after the end of treatment and eradication was considered to be successful if both rapid urease test and histology were negative.
Results:Overall, H.
pylori was eradicated in 84% (72/86) patients on intention‐to‐treat analysis, whereas the per protocol cure rate was 89% (72/81).
Eradication rates were 23/27 (85%) (95% confidence interval (CI): 66–96%), 25/27 (92%) (95% CI: 76–99%) and 24/27 (89%) (95% CI: 71–98%) in the 1‐, 2‐ and 4‐week groups, respectively, on per protocol analysis, and 25/28 (82%) (95% CI: 63–94%), 25/29 (86%) (95% CI: 68–96%) and 24/29 (83%) (95% CI: 64–94%), respectively, on intention‐to‐treat analysis (P > 0.
05, N.
S.
).
No significant differences were observed between groups concerning duodenal ulcer healing, resolution of symptoms and adverse effects.
Conclusions:The 1‐week regimen with ranitidine bismuth citrate, clarithromycin and metronidazole is effective in H.
pylori eradication.
Prolongation of treatment with ranitidine bismuth citrate for 2 or 4 weeks does not achieve a statistically significant more favourable outcome.

Related Results

Different regimens for eradication of Helicobacter pylori infection in children: a randomized controlled trial
Different regimens for eradication of Helicobacter pylori infection in children: a randomized controlled trial
Abstract Eradication of Helicobacter pylori (H. pylori) infection in children is challenging due to increased antibiotic resistance and decreased effectiveness of the cur...
Jinghua Weikang capsule for helicobacter pylori eradication: A systematic review and meta-analysis with trial sequential analysis
Jinghua Weikang capsule for helicobacter pylori eradication: A systematic review and meta-analysis with trial sequential analysis
Background:Helicobacter pylori (H. pylori) infection is one of the most common chronic bacterial infections worldwide. The resistance of H. pylori to antibiotics may increase the r...
Bismuth and Bismuth Alloys
Bismuth and Bismuth Alloys
Abstract The element bismuth, Bi, found in Group 15 (VA) of the Periodic Table, has at no. 83, at wt 208.98. Its valences are +5 and +3. Bismuth is a silvery metal having...
Bismuth and Bismuth Alloys
Bismuth and Bismuth Alloys
Abstract The element bismuth, Bi, found in Group 15 (VA) of the Periodic Table, has at no. 83, at wt 208.98. Its valences are \doc...
Helicobacter pylori infection and related factors among pregnant women at Debre Tabor General Hospital, Northwest Ethiopia, 2021
Helicobacter pylori infection and related factors among pregnant women at Debre Tabor General Hospital, Northwest Ethiopia, 2021
Abstract Introduction: Infection with Helicobacter pylori is one of the most frequent chronic bacterial illnesses in humans, infecting more than half of the world's populat...

Back to Top